skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 1
Patent #:
11136296
Issue Dt:
10/05/2021
Application #:
16603719
Filing Dt:
10/08/2019
Publication #:
20200031775
Pub Dt:
01/30/2020
Inventors:
Hartmut BECK, Raimund KAST, Mark MEININGHAUS, Lisa DIETZ, Chantal FUERSTNER et al
Title:
SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF
Assignment: 1
Reel/Frame:
051401/0430Recorded: 01/02/2020Pages: 14
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
BECK, HARTMUT, DR.
Exec Dt:
10/07/2019
KAST, RAIMUND, DR.
Exec Dt:
10/07/2019
MEININGHAUS, MARK, DR.
Exec Dt:
10/04/2019
DIETZ, LISA, DR.
Exec Dt:
10/07/2019
FUERSTNER, CHANTAL, DR.
Exec Dt:
10/07/2019
STELLFELD, TIMO, DR.
Exec Dt:
10/02/2019
ANLAUF, SONJA
Exec Dt:
10/07/2019
VON BUEHLER, CLEMENS-JEREMIAS, DR.
Exec Dt:
10/14/2019
BAIRLEIN, MICHAELA, DR.
Exec Dt:
10/14/2019
ANLAHR, JOHANNA, DR.
Exec Dt:
10/21/2019
MUENSTER, UWE, DR.
Exec Dt:
10/22/2019
TERJUNG, CARSTEN, DR.
Exec Dt:
10/07/2019
JOERISSEN, HANNAH, DR.
Exec Dt:
10/07/2019
HAUFF, PETER, DR.
Exec Dt:
10/02/2019
MUELLER, JOERG, DR.
Exec Dt:
10/21/2019
DROEBNER, KAROLINE, DR.
Exec Dt:
10/30/2019
NAGEL, JENS, DR.
Exec Dt:
10/15/2019
Assignees:
BAYER AKTIENGESELLSCHAFT
KAISER-WILHELM-ALLEE 1
LEVERKUSEN, GERMANY 51373
BAYER PHARMA AKTIENGESELLSCHAFT
MUELLERSTR. 178
BERLIN, GERMANY 13353
Correspondent:
MCBEE MOORE & VANIK IP, LLC
510 SOUTH MARKET STREET
FREDERICK, MD 21701

Search Results as of: 05/17/2024 09:01 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT